You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mutanome

Showing 1 - 12 of 12
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Carcinoma, Fallopian Tube Cancer, Peritoneal Carcinoma Trial in France, United States (TG4050)

Recruiting
  • Ovarian Carcinoma
  • +2 more
  • Phoenix, Arizona
  • +5 more
Sep 22, 2021

Squamous Cell Carcinoma of Head and Neck Trial in France, United Kingdom, United States (TG4050)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Jacksonville, Florida
  • +5 more
Nov 5, 2021

Melanoma Trial in Wien, Mainz, Mannheim (IVAC MUTANOME, RBL001/RBL002)

Completed
  • Melanoma
  • IVAC MUTANOME, RBL001/RBL002
  • Wien, AT-Wien, Austria
  • +2 more
Jan 14, 2020

Immunogenic Neo-epitopes for Development of Personalised

Unknown status
  • The Initial Aim of This Project is to Perform in Vitro Validation of Neoepitope Candidates Selected From Available Mutanome Data
  • Peptides
  • London, United Kingdom
    Barts Cancer Institute
May 5, 2020

Glioma, Malignant, Antigen-specific Vaccines, Individualized Treatment Trial in Shanghai (NeoPep Vaccine1 plus Poly-ICLC, NeoPep

Recruiting
  • Glioma, Malignant
  • +2 more
  • NeoPep Vaccine1 plus Poly-ICLC
  • NeoPep Vaccine2 plus Poly-ICLC
  • Shanghai, Shanghai, China
    Shanghai 10th People's Hospital
Oct 7, 2022

NSCLC Trial in Ghent (Dendritic cell immunotherapy, Antigen-specific DTH, Control DTH)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Dendritic cell immunotherapy
  • +2 more
  • Ghent, Belgium
    Ghent University Hospital
Dec 23, 2022

Stage IIIA Hepatocellular Carcinoma, Stage IIIB Hepatocellular Carcinoma, Stage IIIC Hepatocellular Carcinoma Trial in Chicago

Completed
Has Results
  • Stage IIIA Hepatocellular Carcinoma
  • +4 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Chicago, Illinois
    Northwestern University
Jan 18, 2022

Melanoma (Skin) Trial in Changsha (Peptide, Anti-PD-1, rhGM-CSF)

Unknown status
  • Melanoma (Skin)
  • Changsha, Hunan, China
    Xiangya Hospital, Central South University
Apr 24, 2020

Samples From Leukemia Patients and Their Donors to Identify

Unknown status
  • Acute Myeloid Leukemia
    • La Jolla, California
    • +1 more
    Mar 3, 2020

    NSCLC Trial in New York, Philadelphia (Pembrolizumab, Carboplatin, Nab-paclitaxel)

    Active, not recruiting
    • Carcinoma, Non-Small-Cell Lung
    • New York, New York
    • +2 more
    Dec 10, 2019

    Small Cell Lung Cancer Trial in Saint Louis Park, Columbus (Topotecan, Pembrolizumab)

    Active, not recruiting
    • Small Cell Lung Cancer
    • Saint Louis Park, Minnesota
    • +1 more
    Jul 29, 2019

    Glioblastoma Trial in Worldwide (APVAC1 vaccine plus Poly-ICLC and GM-CSF, APVAC2 vaccine plus Poly-ICLC and GM-CSF)

    Completed
    • Glioblastoma
    • APVAC1 vaccine plus Poly-ICLC and GM-CSF
    • APVAC2 vaccine plus Poly-ICLC and GM-CSF
    • Copenhagen, Denmark
    • +5 more
    Aug 6, 2018